Retaglutide is a novel GLP-1 receptor agonist currently under investigation for the management of metabolic disorders. This therapy works by mimicking the effects of glucagon-like peptide-1 (GLP-1), a naturally https://sachinguck912985.idblogmaker.com/37879031/retaglutide-a-promising-glp-1-receptor-agonist